💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Brainstorm Cell Therapeutics Inc. (BCLI)
« Back to company indexBCLI Chatter Timeline
Stock Ticker for BCLI
Most Active Tweeters for BCLI
| User | Tweets |
|---|---|
| @Tickeron | 11 |
| @friendva1 | 9 |
| @Uncletrade1 | 5 |
| @AlertTrade | 4 |
| @TortozaLeandro | 4 |
Recent Tweets for BCLI
 |
@Tickeron $BCLI's Aroon indicator drops into Downtrend on November 9, 2021. View odds for this and other indicators:… https://t.co/jaslFDONEn December 3rd 2021, 9:12pm |
 |
@SismasStock $BCLI waiting for Short signal on BCLI https://t.co/Php2HRoRDt December 3rd 2021, 8:12pm |
 |
@Gambiste1 RT @friendva1: $BCLI Senate List 51 sponsors for S.1813 - Accelerating Access to Critical Therapies for ALS Act 500 Million "For purposes… December 3rd 2021, 2:12pm |
 |
@friendva1 $BCLI NurOwn of ‘Meaningful’ Benefit to Earlier Stage Patients, Data Show https://t.co/Pj64dBTc0c December 3rd 2021, 1:12pm |
|
@friendva1 $BCLI Senate List 51 sponsors for S.1813 - Accelerating Access to Critical Therapies for ALS Act 500 Million "For… https://t.co/yjtNfyA0LS December 3rd 2021, 1:12pm |
 |
@StockNewsNow $BCLI BrainStorm Cell Therapeutics to Present New Biomarker Data on NurOwn® at the International Symposium on ALS/M… https://t.co/F6PVeD1wpj December 2nd 2021, 6:12pm |
 |
@Briefingcom $BCLI: Brainstorm Cell Therapeutics to present new biomarker data on NurOwn at the International Symposium on ALS/M… https://t.co/nQj46DRS6H December 2nd 2021, 2:12pm |
 |
@MarcJacksonLA $BCLI BrainStorm Cell Therapeutics to Present New Biomarker Data on NurOwn® at the International Symposium on ALS/M… https://t.co/svbx4pzdSZ December 2nd 2021, 1:12pm |
 |
@FlashAlert_me $BCLI [15s. delayed]: Issued Press Release on December 02, 07:00:00: BrainStorm Cell Therapeutics to Present New Bi… https://t.co/BCUPacXbia December 2nd 2021, 12:12pm |
 |
@James__BondOO7 RT @stock_titan: $BCLI BrainStorm Cell Therapeutics to Present New Biomarker Data on NurOwn® at the International Symposium on ALS/MND http… December 2nd 2021, 12:12pm |
 |
@StockNewsBot2 $BCLI BrainStorm Cell Therapeutics to Present New Biomarker Data on NurOwn® at the International Symposium on ALS/M… https://t.co/Tnkpq8pGbw December 2nd 2021, 12:12pm |
 |
@stock_titan $BCLI BrainStorm Cell Therapeutics to Present New Biomarker Data on NurOwn® at the International Symposium on ALS/M… https://t.co/KwYYJk9rI8 December 2nd 2021, 12:12pm |
|
@Tickeron $BCLI enters an Uptrend as Momentum Indicator exceeded the 0 level on November 24, 2021. View odds for this and oth… https://t.co/PCD65noVzY December 1st 2021, 10:12pm |
 |
@catornadochaser $BCLI over $4 ww December 1st 2021, 4:12pm |
 |
@MechE_Trader $BCLI over 4 look for quick run to $5, then gap fill December 1st 2021, 4:12pm |
|
@MechE_Trader $BCLI looks ready to blow December 1st 2021, 4:12pm |
 |
@Retail_Whale $BCLI added last Friday, recent news has this setup for a large breakout on recent FDA news. Especially if Bio's stay hot December 1st 2021, 3:12pm |
|
@friendva1 $BCLI 5 biomarkers predicted treatment response w 82.5% accuracy https://t.co/c3UnS7LZz8 December 1st 2021, 2:12pm |
 |
@ahighelevation $BCLI Using Biomarkers to Predict Response to Treatment in ALS #biomarker #multiplesclerosis -… https://t.co/WHkMMz3OJX November 30th 2021, 10:11pm |
 |
@altofuertelejos $BCLI looks like a great risk/reward here https://t.co/GfINhggCz6 November 30th 2021, 10:11pm |
|
@Tickeron $BCLI was the market's top gainer this month, soaring +31.61% #BrainstormCellTherapeutics #stockmarket #stock https://t.co/8SWIcFJAe4 November 30th 2021, 9:11pm |
 |
@Sandman7591 $BCLI daily very nice .... watching for BREAK November 30th 2021, 7:11pm |
|
@Retail_Whale $BCLI from Friday's add moving up now also. November 30th 2021, 7:11pm |
 |
@Stock_Wizard $BCLI Clearly we are getting momentum on Nurown on the clinical side with today's presentation. Many, many people… https://t.co/QnYlczeyyL November 30th 2021, 7:11pm |
|
@Tickeron What do you think of this? $BCLI The volume increased for one day, resulting in a record-breaking daily growth of 6… https://t.co/S1yCtCWRaz November 30th 2021, 7:11pm |
 |
@phatoftheland10 New Analyses from the Phase 3 Trial of NurOwn® in ALS at the 4th Annual ALS ONE Research Symposium $bcli… https://t.co/SIXw9qAjqI November 30th 2021, 6:11pm |
 |
@slattii $BCLI on SSR and have ALS pres today around 1pm... Weird price action on last 2 weeks... I would watch the **** out 3.5 ? November 30th 2021, 3:11pm |
 |
@shortablestocks $BCLI is short sale restricted for 2021-11-30. https://t.co/lnUARrLfAn November 30th 2021, 2:11pm |
 |
@Uncletrade1 $BCLI Awaiting buy Signal. Stock Trading Ideas by https://t.co/EAlF3EfmVW #Investing #trading https://t.co/Qt5DoebdDk November 30th 2021, 12:11pm |
|
@friendva1 $BCLI Senate List 49 sponsors for S.1813 - Accelerating Access to Critical Therapies for ALS Act 500 Million "For… https://t.co/HGA0WDxMQY November 30th 2021, 12:11pm |
|
@friendva1 $BCLI close above 200 SMA on the daily chart. Volume +1.5M https://t.co/Xast2clakW November 30th 2021, 3:11am |
 |
@aboutheoptions $BCLI BrainStorm Cell Therapeutics (BCLI) Announces the Presentation of New Analyses from the Phase 3 Trial of NurO… https://t.co/3ZL3AswToD November 30th 2021, 1:11am |
|
@SismasStock $BCLI waiting for Short signal on BCLI https://t.co/l8D3Y619DR November 29th 2021, 6:11pm |
|
@Uncletrade1 $BCLI Waiting for Buy signal on BCLI https://t.co/gsxIpmBfka November 29th 2021, 5:11pm |
|
@Tickeron $BCLI enters an Uptrend because Momentum Indicator exceeded the 0 level on November 24, 2021. View odds for this an… https://t.co/EL23cF33ol November 29th 2021, 5:11pm |
 |
@cherise77 RT @GeorgeB14941177: $BCLI Although the Phase 3 trial was unsuccessful, post hoc analyses revealed the potential for a meaningful treatment… November 29th 2021, 5:11pm |
 |
@GeorgeB14941177 $BCLI Although the Phase 3 trial was unsuccessful, post hoc analyses revealed the potential for a meaningful treatm… https://t.co/a5wgTjxQjb November 29th 2021, 3:11pm |
|
@Tickeron A.I.dvisor made a bullish call on $BCLI, netting in a 28.52% gain over 7 days #BrainstormCellTherapeutics… https://t.co/WCWYTYZGuC November 29th 2021, 3:11pm |
 |
@AlertTrade VOLUME RADAR: $BCLI Brainstorm Cell Therapeutics Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 29th 2021, 2:11pm |
 |
@SparkNewswire $BCLI BrainStorm Cell ALS Candidate Shows Benefit In Patients With Less Severe Disease https://t.co/ru7uuizDVU November 29th 2021, 2:11pm |
 |
@princetongb $BCLI with a new analysis of P3 claiming that early patients were the benefactors of Nurown. Sounds like the anti-a… https://t.co/nPoTntH9VZ November 29th 2021, 2:11pm |
 |
@InvestorDevo Pair this with ALS news we just received and it’s great. MS news should drop soon as well. $BCLI https://t.co/nwm9cgLzF3 November 29th 2021, 2:11pm |
|
@Retail_Whale $BCLI runner candidate today/this week November 29th 2021, 1:11pm |
|
@InvestorDevo RT @manpreetkailon: $BCLI BrainStorm Cell Therapeutics Announces the Presentation of New Analyses from the Phase 3 Trial of NurOwn® in ALS… November 29th 2021, 1:11pm |
 |
@AS_Investing $BCLI BrainStorm Cell Therapeutics Announces the Presentation of New Analyses from the Phase 3 Trial of NurOwn in A… https://t.co/bNexJzm356 November 29th 2021, 1:11pm |
 |
@OpenOutcrier $BCLI (+2.1% pre) Brainstorm Cell Therapeutics (BCLI) Announces Presentation of New Analyses from Phase 3 Trial of… https://t.co/CtPAqappRV November 29th 2021, 1:11pm |
|
@MarcJacksonLA $BCLI BrainStorm Cell Therapeutics Announces the Presentation of New Analyses from the Phase 3 Trial of NurOwn® in… https://t.co/qGXIgHtFrQ November 29th 2021, 1:11pm |
 |
@SwingTradeIdeas $BCLI momentum continuing. Price up another 6.16% since last mention. First mentioned at 07:37 AM ET. Now trading at $4.40. #BCLI November 29th 2021, 1:11pm |
 |
@MarkoJazbinsek $BCLI got filled at 3.74, sold 9/10 already, super sketchy catalyst tho: BrainStorm Cell Therapeutics Announces the… https://t.co/I3FNVZqY7b November 29th 2021, 12:11pm |
|
@SwingTradeIdeas $BCLI is up 10.70% on 235,549 volume. Now trading at $4.14. #BCLI #premarketscan November 29th 2021, 12:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?